Clinical Trials Logo

Infection Wound clinical trials

View clinical trials related to Infection Wound.

Filter by:
  • None
  • Page 1

NCT ID: NCT05153694 Recruiting - Bladder Cancer Clinical Trials

Infectious Complications After Cystectomy: A Prospective Observational Study

Start date: December 1, 2021
Phase:
Study type: Observational

In this study, we evaluate peri- and postoperative parameters of patients undergoing a cystectomy and try to find risk factors for infectious complications. In detail, we analyze their medical history, demographic data, lab values, microbiological tests as well as histological and radiological findings. Furthermore, after discharging our patients, we send them several follow-up questionnaires at regular intervals and offer them free follow-up examinations.

NCT ID: NCT04753723 Completed - Burn Wound Clinical Trials

The Use of a Platform Wound Device for Reducing Infection

Start date: February 8, 2021
Phase: Phase 4
Study type: Interventional

This study will evaluate the safety and efficacy of a novel Platform Wound Device (PWD) in its delivery of a local antibiotic, 0.1% Gentamycin cream, to prevent or treat infection in torso and extremity wounds. The hypothesis is that the PWD will be a safe and effective method to provide topical antibiotics to a torso or extremity wound, non-inferior to the current standard of care. This treatment will reduce or rapidly eradicate infection.

NCT ID: NCT04516148 Completed - Surgery Clinical Trials

A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting

Start date: May 29, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study if to evaluate the effectiveness of prophylactic antibiotics given during surgery in reducing the concentration of bacteria in a burn wound after surgery.

NCT ID: NCT04502914 Withdrawn - Burns Clinical Trials

The Study on Bacterial Load Following Open-to-air Management in Burn Patients.

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Burns are one of the common forms of trauma and are a cause of unintentional death and injury. Management of burns becomes complex due to multiple associated complications, for instance, secondary infection of burn wounds is the most common complication associated with burn injuries. Treatment of bacterial infections with antibiotics is becoming more challenging due to the development of multidrug-resistance. Hence, there is a critical need to investigate and establish non-antibiotic approaches to prevent colonization, control growth, and eliminate bacteria from burn wounds. Recent studies have explored the beneficial effects of open-to-air strategies on wound healing. Based on the evidence, the investigators hypothesize that bacterial load in burn wounds will be lowered when treated with an open-to-air strategy compared to the traditional closed wound approach.

NCT ID: NCT04192435 Recruiting - Anesthesia Clinical Trials

Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery

TRIGS
Start date: May 18, 2022
Phase: Phase 4
Study type: Interventional

This international, multicentre, pragmatic, double-blind, placebo-controlled, randomised trial of TxA versus placebo will enrol 3,300 patients throughout Australia and internationally. This is an effectiveness trial - some elements of the trial are deliberately left to the perioperative clinicians' discretion in order to reflect usual practice and maximise generalisability.

NCT ID: NCT04009772 Recruiting - Infection Wound Clinical Trials

Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section

Start date: July 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Compare between cefepime versus routine antibiotics as a prophylactic antibiotic during emergency cesarean section in a tertiary center of obstetric care

NCT ID: NCT03460262 Not yet recruiting - Infection Wound Clinical Trials

Negative Pressure Wound Therapy for Prevention of Groin Infection Following Vascular Surgery

PICO
Start date: March 15, 2018
Phase: N/A
Study type: Interventional

Surgical site infection in vascular surgery is a relatively common event with reported incidence as high as 43%. When considering the groin alone, the incidence is around 20% (30% when considering any wound complication). This complication may sometimes lead to heavier complication (leg amputation, longer hospital stay, high costs…) and affects the early postoperative quality of life of the patients.

NCT ID: NCT01707654 Completed - Infection Wound Clinical Trials

Repair of Infective Wound Associated With Nerve Defect in the Finger Using A Bipedicled Nerve Flap

Start date: July 2008
Phase: N/A
Study type: Interventional

A combination of soft tissue and digital nerve defects in the finger results in sensory loss of the finger pulp. Reconstruction of these combined injuries is difficult. When the neurocutaneous defect is associated with wound infection, reconstructive alternatives are more limited. From July 2008 to May 2010, a retrospective study was conducted with 9 consecutive postinfection patients who had the neurocutaneous defect of the finger following trauma. The purpose of this retrospective study is to report repair of the complicated infected wound in the finger using the bipedicled nerve flap and to evaluate the efficacy of this technique.

NCT ID: NCT01238276 No longer available - Diabetic Foot Ulcer Clinical Trials

Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion

DAD
Start date: n/a
Phase:
Study type: Expanded Access

This study focuses on a new drug delivery system (Direct Antibiotic Delivery) to treat soft tissue infections. In this study, cefazolin is delivered directly to the target tissues using subcutaneous injection of antibiotic solution and then dispersed using high-frequency external ultrasound. Using this system, a much higher concentration of antibiotic can be achieved than through traditional treatment methods. Unlike traditional delivery methods, Direct Antibiotic Delivery does not rely on blood supply and is beneficial for subjects with Diabetes or subjects who have received radiation therapy and blood supply is limited.